BNP Paribas Financial Markets’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-111
Closed -$7 4527
2018
Q2
$7 Hold
111
﹤0.01% 4398
2018
Q1
$12 Hold
111
﹤0.01% 4193
2017
Q4
$14 Buy
+111
New +$20 ﹤0.01% 4190

BNP Paribas Financial Markets's BTX.WS Position: Q3 2018 in Review

BNP Paribas Financial Markets sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q3 2018, closing a stake of 111 shares — an estimated $7 sold.

BNP Paribas Financial Markets first reported a position in BTX.WS in Q4 2017 and held it in 3 quarters. The position peaked at $14 in Q4 2017. 7 funds tracked by Wall St. Rank hold BTX.WS as of Q3 2018.

  • BNP Paribas Financial Markets reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q3 2018 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 111 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q3 2018, an estimated $7.
  • BNP Paribas Financial Markets first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2017 and held it in 3 quarters.
  • BNP Paribas Financial Markets's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $14 in Q4 2017.
  • 7 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q3 2018.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2018, filed 7 Nov 2018.